The MONET trial: week 144 analysis of the efficacy of darunavir/ritonavir (DRV/r) monotherapy versus DRV/r plus two nucleoside reverse transcriptase inhibitors, for patients with viral load
JR Arribas, N Clumeck, M Nelson, A Hill, Y van Delft, C MoecklinghoffVolume:
13
Year:
2012
Language:
english
Pages:
1
DOI:
10.1111/j.1468-1293.2012.00989.x
File:
PDF, 223 KB
english, 2012